Literature DB >> 30831309

Development of Strategic Plans for Advancing Nursing in Korea.

Eui Geum Oh1, Yeonsoo Jang1, Jeongok Park1, Hyejung Lee1, Heejung Kim1, Ari Min2, Suhee Kim3, Yongmi Kwon1.   

Abstract

PURPOSE: The aim of the study is to evaluate the current and prospective status of nursing in Korea and develop a strategic framework and plan to accommodate the increased demands on nurses in the changing health-care system.
METHODS: This study used a mixed-methods approach including a literature review, an online survey with health-care consumers, expert panel interviews, and an analysis of strengths, weaknesses, opportunities, and threats to develop the strategic plans and framework.
RESULTS: The vision of the strategic framework involved improving health and quality of life, and its mission was to elevate the status of Korea's nursing sector as a key health-care profession through high-quality and innovative nursing education, research, and practice. The five values in accordance with the mission and vision were innovation, creation, collaboration, excellence, and authenticity. Three strategic goals, namely, education, research, and practice, were identified, and 31 related strategic tasks were developed.
CONCLUSION: In response to the rising social demand for a paradigm shift in nursing care services, there is a need for advancements in nursing education, research, and practice in Korea. This study provide some recommendations to achieve these aims.
Copyright © 2019. Published by Elsevier B.V.

Keywords:  education, nursing; health policy; nurse's role; research

Mesh:

Year:  2019        PMID: 30831309     DOI: 10.1016/j.anr.2019.02.003

Source DB:  PubMed          Journal:  Asian Nurs Res (Korean Soc Nurs Sci)        ISSN: 1976-1317            Impact factor:   2.085


  1 in total

1.  Characteristics of early-career nurse researchers negatively impacted during the COVID-19 pandemic: a cross-sectional study.

Authors:  Kana Kazawa; Yoko Shimpuku; Naoki Yoshinaga
Journal:  BMJ Open       Date:  2022-04-20       Impact factor: 3.006

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.